Secondary Logo

Journal Logo

Oxygen and nitric oxide are pulmonary vasodilators in recurrent pulmonary embolism in pigs

Zink, W.1; Weimann, J.1; Gebhard, M. M.2; Martin, E.1; Motsch, J.1

Section Editor(s): Graf, B. M.; Weimann, J.

European Journal of Anaesthesiology: 2000 - Volume 17 - Issue - p 8-9
Abstracts: Third Meeting of the International Society for Medical Gases (ISMG); Heidelberg, Germany, 29 September-1 October 1999
Free

1Department of Anaesthesiology and 2Department of Experimental Surgery, University of Heidelberg, Germany

ABSTRACT NO: 016

Introduction: Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator in animal models of acute [1] and recurrent pulmonary microembolism [2]. However, the vasoconstrictor mechanism affected by iNO in this situation is still unknown. Therefore, in this study, we compared the effects of iNO with inhalation of 100% oxygen (O2) and the combination of both in an animal model of sustained pulmonary hypertension following recurrent pulmonary microembolism.

Methods: Twelve anaesthetized pigs (12.5 ± 1.1 kg BW) were subjected to three pulmonary microembolizations by i.v. injection of polydextrane microspheres (15 mg kg−1; ∅ 300 μm) on days 0, 7 and 49 respectively. One week later (day 56), the mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) were measured at the baseline (FiO2 = 0.21; iNO = 0 ppm), during inhalation of O2 (FiO2 = 1.0; iNO = 0 ppm), iNO (FiO2 = 0.21; iNO = 40 ppm) and O2 + iNO (FiO2 = 1.0; iNO = 40 ppm).

Results: Compared with the baseline (29 ± 2.4 mmHg), mPAP decreased significantly with inhalation of O2 (24 ± 2.1 mmHg), iNO (23 ± 2.3 mmHg) and O2 + iNO (22 ± 2.1 mmHg) (P < 0.05 vs. baseline respectively). FIGURE

Figure

Figure

Conclusions: O2 and iNO are pulmonary vasodilators in this model. Their effects are not additive. Hypoxic pulmonary vasoconstriction seems to be the major vasoconstricting mechanism causing increased pulmonary vascular tone.

Back to Top | Article Outline

References:

1 Böttiger BW et al. Chest 1996; 110: 1041-1047.
2 Weimann J et al. J Crit Care 1999; 14: 133-140.

Section Description

The publication of this supplement has been supported by the sponsors of the Third ISMG Meeting: Abbott, AGA, AstraZeneca, Dräger, Janssen, Medex Medical, Messer Austria, Ohmeda, Pharmacia & Upjohn, Scott Medical Products, Siemens

© 2000 European Society of Anaesthesiology